Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
On Monday, Tesla sent an email to employees saying it was laying off around 10 percent of its workforce, or roughly 14,000 ...
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
Drugmakers and other health-focused companies are laying off hundreds of Bay Area workers, collectively, all close to the ...
Rivian said the latest round of cuts affect about 1% of its workforce.
Tesla plans to lay off more than 10% of its employees, multiple news outlets report, as the electric vehicle maker continues ...
After reporting dismal first-quarter sales, Tesla is planning to lay off about a tenth of its workforce as it tries to cut ...
Amgen, with its obesity candidate MariTide and other promising treatments in its pipeline, could potentially surpass Eli Lilly in the obesity market. Amgen's stock is undervalued compared to Eli ...
Not only did it help patients lose weight, but they were also able to keep the weight off for up to 150 days following the last dose of the medicine. Amgen plans on releasing results from phase 2 ...